CATALYSTYahoo • 1d ago
Why Did Insmed Stock Jump?For questions about this article or underlying research, email help@trefis.com.
Why LQDA Stock slipped -1.60% Today — RQD Quant Desk Flash
$44.99 -1.60% NASDAQ • Public Delayed / 60s Snapshot
Liquidia Corporation (LQDA) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh money.
ROARABLE D+ • SELL / AVOID
Cap $4.03B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERSELL / AVOID • D+
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C+
Each axis scored 0–20
12M PRICE TARGET CONE+0% Base Target
WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($2.5M)
44% PutsMax Pain: $44.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why LQDA Stock slipped -1.60% Today — RQD Quant Desk Flash
Liquidia Corporation (LQDA) slipped -1.60% to $44.99 as options desks priced 56% call premium vs. 44% put protection around the $44 max-pain magnet. Stretched risk/reward at current multiples (-13% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 32% of its 52-week range ($22.21 – $93.61) with RSI-14 at 52.5 (NEUTRAL RANGE).
- ▸Whale Options Positioning: $2.5M in bullish call flow vs. $2.0M in put flow (Put/Call 0.79x, implied earnings swing ±6.6%).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 44% gross margin and $0 annual free cash flow.
Live LQDA Headlines & Catalysts
RISK WATCHYahoo • 2d ago
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue EstimatesStoke Therapeutics (STOK) delivered earnings and revenue surprises of -22.73% and +35.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
MARKET WIREYahoo • 2d ago
What Is Behind Liquidia's Lead Over Its Industry?For questions about this article or underlying research, email help@trefis.com.
CATALYSTYahoo • 3d ago
Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?LQDA's Q3 results will spotlight the impact of its legal settlement with UTHR, cash flow pressures, profitability prospects and pipeline progress.
CATALYSTYahoo • 3d ago
EyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?EyePoint (EYPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CATALYSTYahoo • 5d ago
Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?Liquidia Corporation (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CATALYSTBenzinga • 5d ago
Range Resources, Xtend AI Robotics, Oruka Therapeutics And Other Big Stocks Moving Higher On MondayU.S. stocks rose; Dow gained 350 points. Range Resources jumped 15% on EQT acquisition, while Surgery Partners and others posted sharp gains.
RISK WATCHYahoo • 7d ago
Can Liquidia (LQDA) Still Justify Its Price After Settlement?Liquidia has seen sharp swings in recent years, and the question now is whether the current share price lines up with what its earnings can reasonably support. With such a volatile backdrop, the issue is not just where t
MARKET WIREYahoo • 9d ago
United Therapeutics' Tyvaso Outlook Faces Near-Term Pressure After Liquidia Settlement, RBC SaysUnited Therapeutics (UTHR) faces limited near-term upside for Tyvaso following the Liquidia (LQDA) s
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring LQDA)
- ✓Live walkthrough of LQDA's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
LQDA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +14.92%▼ DESCENDING CHANNEL
2026-10-30O $44.56H $46.29L $44.24C $45.06VOL 2.09M
RES: $66.01SUP: $14.53SMA50: $52.99SMA200: $54.30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
LQDA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
14.6%/yr Implied 5Y Growth
vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on LQDA today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for LQDA. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LQDA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
LQDA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is LQDA stock moving today?
Why LQDA Stock slipped -1.60% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-13% return on capital) under elevated 10-year interest-rate pressure.